Quantification of unfractionated heparin in human plasma and whole blood by means of novel fluorogenic anti-FXa assays
Killard, A. (2011) Quantification of unfractionated heparin in human plasma and whole blood by means of novel fluorogenic anti-FXa assays. Journal of Pharmaceutical and Biomedical Analysis, 56 (5). pp. 992-997. ISSN 0731-7085 Available from: http://eprints.uwe.ac.uk/15653
Full text not available from this repository
Publisher's URL: http://dx.doi.org/10.1016/j.jpba.2011.07.025
Novel and sensitive plate-based fluorogenic anti-factor Xa (FXa) assays were investigated to quantify unfractionated heparin (UFH) in human plasma and whole blood within the therapeutic ranges of 0–1.6 U/mL and 0–0.8 U/mL, respectively. Two fluorogenic anti-FXa assay methods were defined for low (0–0.6 U/mL) and high (0.6–1.2 U/mL) pharmacologically relevant UFH concentration ranges in pooled human plasma. In both cases significant differences were observed at intervals of 0.2 U/mL (P < 0.05). The semi-logarithmic plots of the calibration curves in the low and high UFH range were both fitted to linear regressions with correlation coefficients of 0.96 and >0.99, respectively. The assay was also optimized for whole blood which was capable of differentiating UFH concentrations at intervals of 0.2 U/mL (P < 0.05) in the range of 0–0.4 U/mL. The statistically different results were fitted to a linear regression with a correlation coefficient of >0.99. The results obtained in this study could assist diagnostic laboratories towards improved monitoring of UFH therapy.